- Home
- EKSO
as of 12-12-2025 4:00pm EST
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN RAFAEL |
| Market Cap: | 7.7M | IPO Year: | N/A |
| Target Price: | $7.75 | AVG Volume (30 days): | 314.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.73 - $14.97 | Next Earning Date: | 10-28-2025 |
| Revenue: | $14,749,000 | Revenue Growth: | -16.59% |
| Revenue Growth (this year): | -16.32% | Revenue Growth (next year): | 54.65% |
AI-Powered EKSO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Ekso Bionics Holdings Inc. (EKSO)
Chief Financial Officer
Avg Cost/Share
$4.70
Shares
1,238
Total Value
$5,818.60
Owned After
24,771
SEC Form 4
Chief Operating Officer
Avg Cost/Share
$4.70
Shares
270
Total Value
$1,269.00
Owned After
26,941
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$4.80
Shares
11,288
Total Value
$54,182.40
Owned After
24,771
SEC Form 4
Chief Operating Officer
Avg Cost/Share
$4.80
Shares
9,723
Total Value
$46,670.40
Owned After
26,941
SEC Form 4
CEO
Avg Cost/Share
$4.80
Shares
23,315
Total Value
$111,912.00
Owned After
78,777
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Wong Jerome | EKSO | Chief Financial Officer | Dec 9, 2025 | Sell | $4.70 | 1,238 | $5,818.60 | 24,771 | |
| Jones Jason C | EKSO | Chief Operating Officer | Dec 9, 2025 | Sell | $4.70 | 270 | $1,269.00 | 26,941 | |
| Wong Jerome | EKSO | Chief Financial Officer | Nov 10, 2025 | Sell | $4.80 | 11,288 | $54,182.40 | 24,771 | |
| Jones Jason C | EKSO | Chief Operating Officer | Nov 10, 2025 | Sell | $4.80 | 9,723 | $46,670.40 | 26,941 | |
| Davis Scott G. | EKSO | CEO | Nov 10, 2025 | Sell | $4.80 | 23,315 | $111,912.00 | 78,777 |
Compare EKSO vs Leading Stocks
See how EKSO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "EKSO Ekso Bionics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.